跳转到主要内容
搜索

临床前

注册

最新资源

精选资源

Upcoming preclinical webinars

网络研讨会

Explore Smarter, Faster PK/PD with Phoenix

2026 年 6 月 23 日 – 10-11 AM ET/CET/JST
网络研讨会

Model Smarter, Not Harder: Introducing Model Designer

2026 年 6 月 30 日, 10:00 – 11:00 AM ET | 2026 年 7 月 2 日, 10:00 – 11:00 AM JST & 10:00 –
网络研讨会

BioSpace webinar: Streamlining Nonclinical Development with FDA NAMs

2026 年 7 月 1 日 – 10–11am ET

Latest preclinical blogs

在以下活动中与我们的专家会面

会议

Bio International Convention 2026

2026 年 6 月 22 - 25 日 — 波士顿，马萨诸塞州 — 展位 1304
会议

2026 ACCP Annual Meeting

September 27 - 29, 2026 – Bethesda N Marriott Hotel & Conf Ctr N Bethesda, MD
会议

BioTechX Europe 2026

2026 年 10 月 6 - 8 日

All preclinical resources

Machine Learning based drug renal clearance predictor development and application

Certara Products - Simcyp, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Poster

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Poster

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Certara Services, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Therapeutic Specialties, Poster

Building IND-Ready and Investor-Ready Development Programs

Certara Services, Clinical Pharmacology, Drug Development, Modeling and Simulation, New Approach Methodologies (NAMs), Webinar

2026 Simcyp Workshops

Certara Products - Simcyp, Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Brochure

Model Smarter, Not Harder: Introducing Model Designer

Certara Products - Phoenix, Modeling and Simulation, Modeling and Simulation - PK/PD, Webinar

Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Poster

Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients

Biologics, Modeling and Simulation, Modeling and Simulation - QSP, Publication

Applying AI-Driven Biosimulation to Drug Discovery

Biologics, Certara Products, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Video

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

Biologics, Certara Products - Certara IQ, Modeling and Simulation - QSP, Publication

Certara’s NLME Engine: Setting the Standard for Run Speed and Stability

Certara Products - Phoenix, Fact Sheet

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Certara Products - Certara IQ, Certara Products - Simcyp, Drug Development, Drug-Drug Interactions (DDI), ICH M15, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), On-Demand Webinar
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software